Exchange: NASDAQ·Updated 07:35 PM EDT

NXTSNexentis Technologies Inc.

$3.73
$0.49
(11.39%)
Today
Closed $3.81
$0.08
(2.10%)
After Hours
Mkt Cap$6.25M
Vol107,227.00
News
all
press releases
News Placeholder
AI, Biotech, And Healthcare Catalysts Drive Momentum
Several emerging public companies are attracting attention as artificial intelligence, healthcare innovation, medical technology, and international commercialization strategies continue converging across the market. From AI-powered drug discovery and regenerative medicine expansion to precision dermatology and medical device innovation, recent developments highlight how smaller companies are positioning themselves around some of the fastest-growing sectors in healthcare and technology. $TGNT, $NXTS, $AZTR, $ADTX, $TNON, $PFE
24-7 Market News
News Placeholder
Dow Jumps 200 Points; Outdoor Holding Shares Fall After Q4 Results
US stocks rise, Dow up over 200 points. Financial shares jump 0.9% while communication services stocks fall 2.3%. Nexentis Technologies Inc shares surge 208%.read more...
Benzinga
News Placeholder
AI Meets Mitochondrial Drug Discovery
Artificial intelligence continues to reshape pharmaceutical research, and the latest example comes from Nexentis Technologies (NASDAQ:NXTS), whose wholly owned subsidiary, MitoCareX Bio, has launched a new drug discovery initiative aimed at accelerating the identification of novel small-molecule therapies.
24-7 Market News
<
...
1
>

Advertisement|Remove ads.